Page last updated: 2024-11-02

pd 98059 and Brain Neoplasms

pd 98059 has been researched along with Brain Neoplasms in 16 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
"We previously demonstrated that sulforaphane (SFN) inhibited invasion via sustained activation of ERK1/2 in human glioblastoma cells."7.85Sulforaphane-cysteine induces apoptosis by sustained activation of ERK1/2 and caspase 3 in human glioblastoma U373MG and U87MG cells. ( Geng, Y; Hu, Y; Lin, K; Tian, H; Wu, S; Wu, W; Yang, G; Zhou, Y, 2017)
"In human astrocytoma U373 MG cells that express histamine H1 receptors (180 +/- 6 fmol/mg protein) but not H2 or H3 receptors, histamine stimulated mitogenesis as assessed by [3H]-thymidine incorporation (173 +/- 2% of basal; EC50, 2."7.71Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells. ( Arias-Montaño, JA; Hernández-Angeles, A; Ortega, A; Soria-Jasso, LE, 2001)
"We have recently shown that endothelin-1 activates two types of Ca2+-permeable nonselective cation channels (NSCC-1 and NSCC-2) in C6 glioma cells."7.71Effects of extracellular Ca2+ influx on endothelin-1-induced intracellular mitogenic cascades in C6 glioma cells. ( Hashimoto, N; Kawanabe, Y; Masaki, T, 2002)
"Notably, co-treatment of C6 glioma cells with 400 µmol/l NaHS and AOAA (an inhibitor of CBS) largely suppressed the above NaHS-induced effects."5.42Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways. ( Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y, 2015)
"We previously demonstrated that sulforaphane (SFN) inhibited invasion via sustained activation of ERK1/2 in human glioblastoma cells."3.85Sulforaphane-cysteine induces apoptosis by sustained activation of ERK1/2 and caspase 3 in human glioblastoma U373MG and U87MG cells. ( Geng, Y; Hu, Y; Lin, K; Tian, H; Wu, S; Wu, W; Yang, G; Zhou, Y, 2017)
"In human astrocytoma U373 MG cells that express histamine H1 receptors (180 +/- 6 fmol/mg protein) but not H2 or H3 receptors, histamine stimulated mitogenesis as assessed by [3H]-thymidine incorporation (173 +/- 2% of basal; EC50, 2."3.71Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells. ( Arias-Montaño, JA; Hernández-Angeles, A; Ortega, A; Soria-Jasso, LE, 2001)
"We have recently shown that endothelin-1 activates two types of Ca2+-permeable nonselective cation channels (NSCC-1 and NSCC-2) in C6 glioma cells."3.71Effects of extracellular Ca2+ influx on endothelin-1-induced intracellular mitogenic cascades in C6 glioma cells. ( Hashimoto, N; Kawanabe, Y; Masaki, T, 2002)
"Notably, co-treatment of C6 glioma cells with 400 µmol/l NaHS and AOAA (an inhibitor of CBS) largely suppressed the above NaHS-induced effects."1.42Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways. ( Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y, 2015)
"We previously reported that BC brain metastases, in a rat syngeneic model developed in our laboratory, have high expression and activity of MMP2."1.34MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. ( Kim, HT; Lungu, G; Mendes, O; Stoica, G, 2007)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's12 (75.00)29.6817
2010's3 (18.75)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, S1
Zhou, Y1
Yang, G1
Tian, H1
Geng, Y1
Hu, Y1
Lin, K1
Wu, W1
Zhen, Y1
Zhang, W1
Liu, C1
He, J1
Lu, Y1
Guo, R1
Feng, J1
Zhang, Y1
Chen, J1
Tencheva, TsS2
Panov, IR2
Kambe, A1
Yoshioka, H1
Kamitani, H1
Watanabe, T1
Baek, SJ1
Eling, TE1
Hueng, DY1
Lin, GJ1
Huang, SH1
Liu, LW1
Ju, DT1
Chen, YW1
Sytwu, HK1
Chang, C1
Huang, SM1
Yeh, YS1
Lee, HM1
Ma, HI1
Yanamandra, N1
Gumidyala, KV1
Waldron, KG1
Gujrati, M1
Olivero, WC1
Dinh, DH1
Rao, JS2
Mohanam, S1
Zhan, Y1
O'Rourke, DM1
Song, H1
Moon, A1
Mendes, O1
Kim, HT1
Lungu, G1
Stoica, G1
Hung, JJ1
Cheng, TJ1
Lai, YK1
Chang, MD1
Castigli, E1
Arcuri, C1
Giovagnoli, L2
Luciani, R1
Secca, T1
Gianfranceschi, GL1
Bocchini, V1
Lakka, SS1
Jasti, SL1
Kyritsis, AP1
Yung, WK1
Ali-Osman, F1
Nicolson, GL1
Ramer, R1
Brune, K1
Pahl, A1
Hinz, B1
Hernández-Angeles, A1
Soria-Jasso, LE1
Ortega, A1
Arias-Montaño, JA1
Kawanabe, Y1
Hashimoto, N1
Masaki, T1

Other Studies

16 other studies available for pd 98059 and Brain Neoplasms

ArticleYear
Sulforaphane-cysteine induces apoptosis by sustained activation of ERK1/2 and caspase 3 in human glioblastoma U373MG and U87MG cells.
    Oncology reports, 2017, Volume: 37, Issue:5

    Topics: Apoptosis; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine

2017
Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways.
    Oncology reports, 2015, Volume: 34, Issue:5

    Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclo

2015
Intracerebral development of transplanted glioblastoma C6 cells in rats after preliminary exposure to neuropeptides and an MAPK inhibitor.
    Neuroscience and behavioral physiology, 2008, Volume: 38, Issue:9

    Topics: Animals; Basic-Leucine Zipper Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Prolife

2008
The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
    Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:12

    Topics: Activating Transcription Factor 3; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Brain

2009
Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.
    Journal of neuro-oncology, 2011, Volume: 104, Issue:1

    Topics: Analysis of Variance; Animals; Benzamides; Brain Neoplasms; Cell Line, Transformed; Cell Proliferati

2011
Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.
    Oncogene, 2004, Mar-18, Volume: 23, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Biological Assay; Brain Neoplasms; Cathepsin B; Cell Line, Tumor;

2004
SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.
    Cancer research, 2004, Nov-15, Volume: 64, Issue:22

    Topics: Brain Neoplasms; Cell Line, Tumor; Chromones; Enzyme Activation; ErbB Receptors; Flavonoids; Gliobla

2004
Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways.
    Neuroscience research, 2006, Volume: 56, Issue:1

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Enzyme Activation; Enzyme Inhibitors; Flavonoids;

2006
MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2.
    Clinical & experimental metastasis, 2007, Volume: 24, Issue:5

    Topics: Animals; Astrocytes; Brain Neoplasms; Culture Media, Conditioned; Disease Models, Animal; Female; Fl

2007
[Intracerebral progression of the transplanted rat C6 glioblastoma cells pretreated with neuropeptides and MAPK inhibitor].
    Morfologiia (Saint Petersburg, Russia), 2007, Volume: 132, Issue:6

    Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Brain Neoplasms; Cell Line, Tu

2007
Differential activation of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinases confers cadmium-induced HSP70 expression in 9L rat brain tumor cells.
    The Journal of biological chemistry, 1998, Nov-27, Volume: 273, Issue:48

    Topics: Animals; Brain Neoplasms; Cadmium Chloride; Calcium-Calmodulin-Dependent Protein Kinases; Cell Nucle

1998
Interleukin-1beta induces apoptosis in GL15 glioblastoma-derived human cell line.
    American journal of physiology. Cell physiology, 2000, Volume: 279, Issue:6

    Topics: Antigens, Polyomavirus Transforming; Apoptosis; Brain Neoplasms; Cytoskeleton; DNA Fragmentation; En

2000
Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades.
    Clinical & experimental metastasis, 2000, Volume: 18, Issue:3

    Topics: Brain Neoplasms; Enzyme Inhibitors; Flavonoids; Glioma; Humans; JNK Mitogen-Activated Protein Kinase

2000
R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism.
    Biochemical and biophysical research communications, 2001, Sep-07, Volume: 286, Issue:5

    Topics: Analgesics, Non-Narcotic; Arachidonic Acids; Blotting, Western; Brain Neoplasms; Cannabinoid Recepto

2001
Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells.
    Journal of neuro-oncology, 2001, Volume: 55, Issue:2

    Topics: Astrocytoma; Brain Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Enzyme Ac

2001
Effects of extracellular Ca2+ influx on endothelin-1-induced intracellular mitogenic cascades in C6 glioma cells.
    European journal of pharmacology, 2002, Jan-25, Volume: 435, Issue:2-3

    Topics: Acetamides; Animals; Brain Neoplasms; Calcium; Calcium Channel Blockers; Calcium Channels; DNA; Drug

2002